ISO-690 (author-date, English)

ELRAKAYBI, Asmaa, HUG, Martin J., SEUFERT, Jochen und GÜNTHER, Stefan, 2023. Mechanistic insights into the effects of empagliflozin in patients with type 2 diabetes and heart failure. Freiburg: Universität.

Elsevier - Harvard (with titles)

Elrakaybi, A., Hug, M.J., Seufert, J., Günther, S., 2023. Mechanistic insights into the effects of empagliflozin in patients with type 2 diabetes and heart failure. Universität, Freiburg. https://doi.org/10.6094/UNIFR/233278

American Psychological Association 7th edition

Elrakaybi, A., Hug, M. J., Seufert, J., & Günther, S. (ca. 2023). Mechanistic insights into the effects of empagliflozin in patients with type 2 diabetes and heart failure [Universität; Cd]. https://doi.org/10.6094/UNIFR/233278

Springer - Basic (author-date)

Elrakaybi A, Hug MJ, Seufert J, Günther S (2023) Mechanistic insights into the effects of empagliflozin in patients with type 2 diabetes and heart failure. Universität

Juristische Zitierweise (Stüber) (Deutsch)

Elrakaybi, Asmaa/ Hug, Martin J./ Seufert, Jochen/ Günther, Stefan, Mechanistic insights into the effects of empagliflozin in patients with type 2 diabetes and heart failure, Freiburg 2023.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.